Improved patient safety, efficient dose administration, and seamless interoperability for advanced infusion delivery are several advantages offered by next-generation IV infusion pumps. Novel utilization in existing treatments and promising discovery of innovation pumps have led to the expansion of the next-generation IV infusion pumps market.
These developments improve patient outcome as well as offer clinicians with patient-specific data to take better informed decisions. Moreover, the rising trend of wireless infusion pumps and wider scope of application in home care settings are factors that are expected to drive market growth further.
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/15781
The global next-generation IV infusion pumps market was valued at over US$ 4 Bn in 2018, and is expected to exhibit a CAGR of 6% during the forecast period (2019–2029).
Company Profiles:
- Becton, Dickinson and Company (CareFusion)
- Baxter International Inc.
- Fresenius Kabi AG
- B. Braun Melsungen AG
- Smiths Medical (Smiths Group plc.)
- ICU Medical (Hospira Inc.)
- iRadimed Corporation
- Zyno Medical
- Medtronic Plc
- Terumo Corporation
- Nipro Corporation
- Summit Medical Products, Inc
- Ambu A/S
- Gamastech S.R.L
- vTitan
- Acromed AG
